Topics

SMA Moment: Will Gene Therapy Shift Treatment, Costs of Muscle Disease?

07:05 EDT 2 May 2019 | Xconomy

This is a big moment for people diagnosed with spinal muscular atrophy, or SMA, a rare and potentially lethal genetic disorder that destroys muscles. For decades, there was no way to change the trajectory of their disease. They now have one marketed medicine, and this month, chances are they’ll have another: a gene therapy that […]

Original Article: SMA Moment: Will Gene Therapy Shift Treatment, Costs of Muscle Disease?

NEXT ARTICLE

More From BioPortfolio on "SMA Moment: Will Gene Therapy Shift Treatment, Costs of Muscle Disease?"

Quick Search

Relevant Topic

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...